Numan
United Kingdom
- London, England
- 07/02/2022
- Series B
- $60,100,000
We're on a mission to fix ill health for men where they feel it most. It’s a decades-old problem: men aren’t seeking the healthcare that they need. Our survey revealed that 4 out of 10 men haven’t visited a doctor in over a year, and 1 out of 10 can’t even remember the last time they saw a doctor. We help solve the issues that men often leave untreated - not the life-threatening stuff, but the kinds of health problems that can be swept under the rug and may not be outwardly visible.
We're a digital health platform for men - providing access to expert advice, medication, diagnostics and supplements.
At Numan, we help men do something about their health, and live longer, healthier lives.
- Industry Wellness and Fitness Services
- Website https://www.numan.com/
- LinkedIn https://www.linkedin.com/company/numan-com/about/
Related People
Sokratis PapafloratosFounder
United Kingdom -
London, England
Technology entrepreneur and angel investor.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)